Patient‑Centered Core Impact Sets: What They are and Why We Need Them April 01, 2022 Share this page Recommendations on how to move the goal of a patient centered core impact set forward through collaboration, leadership, and establishment of a patient-centered core impact set development blueprint with supporting tools. Patient-Focused Drug Development (PFDD) Related Articles More than 500 Advocates Participated in RARE Across America 2026 August 31, 2026 A Mid-Year State Policy Recap July 22, 2026 FDA Rare Disease Roundtable – June 3, 2026 June 04, 2026 See All News